scholarly journals Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies

2011 ◽  
Vol 171 (6) ◽  
Author(s):  
Connie E. Chen ◽  
Sanket S. Dhruva ◽  
Lisa A. Bero ◽  
Rita F. Redberg
2009 ◽  
Vol 37 (3) ◽  
pp. 527-530
Author(s):  
Pooja Nair

In March 2009, the Supreme Court held in Wyeth v. Levine that federal drug labeling laws do not pre-empt state tort claims against drug manufacturers. The decision surprised many Court watchers, coming on the heels of a 2008 decision, Riegel v. Medtronic, in which the Court found that the Food, Drug, and Cosmetic Act (FDCA) does pre-empt state-law claims for injuries caused by medical devices that received premarket approval from the Food and Drug Administration. Wyeth dealt an immediate and surprising blow to the pharmaceutical industry’s principal strategy for avoiding tort lawsuits, but failed to clarify the Court’s overall pre-emption jurisprudence.


Ophthalmology ◽  
2017 ◽  
Vol 124 (8) ◽  
pp. 1237-1246
Author(s):  
Anand D. Gopal ◽  
Vinay K. Rathi ◽  
Christopher C. Teng ◽  
Lucian Del Priore ◽  
Joseph S. Ross

2017 ◽  
Vol 156 (2) ◽  
pp. 285-288 ◽  
Author(s):  
Vinay K. Rathi ◽  
Bo Wang ◽  
Joseph S. Ross ◽  
Nicholas S. Downing ◽  
Aaron S. Kesselheim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document